Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. | 51,046 | reported | 01 Apr 2025 | tx 2+161,392 |
| Monopar Therapeutics | 22,124.8 | reported | 31 Mar 2022 | tx 25+404,044−15,686 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2025 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 110,346 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 51,046 | 0.00 USD | deriv |
| 31 Mar 2022 | EXERCISE | Monopar Therapeutics | 1,606 | — | |
| 31 Mar 2022 | TAX_WITHHOLDING | Monopar Therapeutics | 471 | 2.55 USD | |
| 31 Mar 2022 | EXERCISE | Monopar Therapeutics | 1,606 | 0.00 USD | deriv |
| 02 Feb 2022 | GRANT_AWARD | Monopar Therapeutics | 67,251 | 0.00 USD | deriv |
| 02 Feb 2022 | GRANT_AWARD | Monopar Therapeutics | 88,874 | 0.00 USD | deriv |
| 31 Dec 2021 | EXERCISE | Monopar Therapeutics | 1,606 | — | |
| 31 Dec 2021 | TAX_WITHHOLDING | Monopar Therapeutics | 556 | 3.21 USD | |
| 31 Dec 2021 | EXERCISE | Monopar Therapeutics | 1,606 | 0.00 USD | deriv |
| 01 Jan 2022 | TAX_WITHHOLDING | Monopar Therapeutics | 671 | 3.21 USD | |
| 01 Jan 2022 | EXERCISE | Monopar Therapeutics | 1,937 | — | |
| 01 Jan 2022 | EXERCISE | Monopar Therapeutics | 1,937 | 0.00 USD | deriv |
| 30 Sept 2021 | TAX_WITHHOLDING | Monopar Therapeutics | 471 | 4.87 USD | |
| 30 Sept 2021 | EXERCISE | Monopar Therapeutics | 1,606 | — | |
| 30 Sept 2021 | EXERCISE | Monopar Therapeutics | 1,606 | 0.00 USD | deriv |
| 30 Jun 2021 | TAX_WITHHOLDING | Monopar Therapeutics | 942 | 5.89 USD | |
| 30 Jun 2021 | EXERCISE | Monopar Therapeutics | 3,212 | — | |
| 30 Jun 2021 | EXERCISE | Monopar Therapeutics | 3,212 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | Monopar Therapeutics | 36,077 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | Monopar Therapeutics | 25,697 | 0.00 USD | deriv |
| 01 Jan 2021 | EXERCISE | Monopar Therapeutics | 1,937 | — | |
| 01 Jan 2021 | TAX_WITHHOLDING | Monopar Therapeutics | 671 | 6.12 USD | |
| 01 Jan 2021 | EXERCISE | Monopar Therapeutics | 1,937 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | Monopar Therapeutics | 7,748 | 0.00 USD | deriv |